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. However, DNA-based analyses have expanded our horizon by generating enormous new data sets that can be mined for information on the composition and functional properties of vastly greater numbers of microbial communities. For example, the Human Microbiome Project (HMP) 2 by the US National Institutes of Health has produced a 2.3 terabyte 16S ribosomal RNA metagenomic data set of over 35 billion reads taken from 690 samples from 300 US subjects, across 15 body sites. Large-scale endeavours (for example, the HMP and also the European project, MetaHIT 3 ) are already providing a preliminary understanding of the biology and medical significance of the human microbiome and its collective genes (the metagenome).
The aim of these projects, particularly the HMP, is to characterize the compositional range of the 'normal' microbiome of healthy individuals. Important questions concerning the commonalities and differences among healthy individuals in both microbial taxa and functional pathways are being addressed. The presence of major clustering patterns at body sites such as the vagina 4 and the gastrointestinal tract 5 provide new ways to classify individuals and possibly their disease risks. Substantial progress has been made in developing the tools for inquiry and in defining the overarching concepts that advance the field. However, the subject is vast, and the implications for human health and disease are wide-ranging. The study of humans and model animal systems with strong phenotypes is essential for making progress in this field of applied genetics. Although a focus on bacteria is important, inquiries aimed at archaea, viruses and retroviruses are also needed.
The purpose of this Review is to develop the theoretical basis for investigating how microbiome composition and function affect human health. We provide examples of applying this knowledge to better understand human health, and we discuss how microbiome changes could alter host-microbiome interactions to mitigate disease. We also consider the next steps in the development of this field, particularly regarding the need to focus on the inheritance of the microbiome and on its involvement in modulating complex traits.
Characterizing the microbiome Animals have had residential microbes carrying out metabolic functions for at least 500 million years, at a conservative estimate 6, 7 . Extensive congruent phylogenies of animal hosts and their microbiota, involving both individual organisms and whole microbial populations 1, 8, 9 , suggest the existence of specific selection based on coadaptation. Cooperative interactions between microbes and their hosts typically involve microbial participation in host functions such as defence, metabolism and reproduction 10 . For example, comparing germ-free and normal mice indicates that microbiota are responsible for most of the metabolites that are detected in plasma 11 . Below we describe the efforts to categorize the composition and complex dynamics of our microbiota. Functional variation of host microbiota can be mediated by the introduction or extinction of particular microbial groups or by a change in population structure High-throughput sequencing has revealed substantial intra-individual microbiome variation at different anatomical sites, and inter-individual variation at the same anatomical sites 4, 5 ,25,52,89,93 . However, higher-level (for example, at the level of phyla) taxonomic features display temporal (longitudinal) stability in individuals at specific anatomical sites. Such site-specific differences and the observed conservation between human hosts provide an important framework to determine the biological and pathological significance of a particular microbiome composition. The figure indicates the relative proportion of sequences determined at the taxonomic phylum level at eight anatomical sites. Certain features, such as the presence (+) or absence (-) of Helicobacter pylori, can lead to permanent and marked perturbations in community composition 93 .
16S ribosomal RNA
A component of the 30S small subunit of prokaryotic ribosomes. Sequencing of the 16S rRNA has been used to identify prokaryotic taxonomy in complete environmental samples such as the microbiome.
Microbiome
The totality of microbes, their genetic information and the milieu in which they interact. Microbiomes typically consist of environmental or biological niches containing complex communities of microbes.
alterations can in turn be induced through selection by environmental factors 10, 15 , such as dietary changes or exposure to antibiotics 10, 15 . Tools for studying the metagenome. The taxonomic diversity that is inherent in complex environmental communities and the task of identifying specific associations with host traits create unique challenges. One approach to metagenome analysis involves assigning unassembled sequences generated by shotgun highthroughput sequencing (HTS) 16 to the NCBI nonredundant Clusters of Orthologous Groups (COG) or the Kyoto Encyclopedia of Genes and Genomes (KEGG) databases 17 . This method facilitates the assessment of interactions that occur within the microbiome, and potentially between a microbiome and its host 18 . However, because a substantial fraction of the metagenome (~33%) is not well-represented by reference genomes, this strategy provides only a limited understanding of the functional potential of the microbiota. An alternative approach is to use catalogues of known genes to identify functional clusters in a sample; such clusters could correspond to the proposed taxonomic enterotypes 5 . A catalogue of the microbial genes present in the human gut, for example, is being generated using several approaches including sequencing, assembling and characterizing non-redundant microbial genes from faecal samples 19 , and whole-genome sequencing of reference microbial species 20 . As technologies for sequencing and bioinformatics continue to evolve (see REF. 21 for a review of the state-of-the-art technologies), scientific priorities will include elucidating the 'core' metagenome that occupies a specific human niche and discerning the differences between normal and diseased hosts. As an example of the latter goal, Greenblum et al. 22 applied new tools to understand interhost metagenomic variation in relation to phenotypes such as obesity and inflammatory bowel disease (IBD). By categorizing metagenomic sequences based on gene function, they constructed communitylevel metabolic networks varying in gene abundance, and examined the topological features of these networks in relation to host phenotype. Their analysis identified specific network topologies related to obesity and IBD; skewed topologies chiefly differ in genes related to host interactivity, particularly metabolic functions. Such topological tools can now be applied to explore differences in other host disease states.
Taxonomic variation.
The composition of the microbiome varies by anatomical site (FIG. 1) . The primary determinant of community composition is anatomical location: interpersonal variation is substantial 23, 24 and is higher than the temporal variability seen at most sites in a single individual 25 . The temporal stability observed at an anatomical site suggests that individuals can be grouped according to the major enterotypes present in the colon 5 or the vagina 4 . However, minor perturbations such as dietary changes can rapidly cause substantial intestinal metagenomic changes, and enterotypes are known to cluster based on the dietary abundance of animal protein relative to carbohydrate 26 . Similarly, nasopharyngeal microbiota in young children varies seasonally 24 , and vaginal microbiota varies with menses 4 . In the absence of marked perturbations the aggregate microbiota of an individual varies rather narrowly within host-specific boundaries; the basis of such boundaries have not been established, but may represent Nash equilibria 13 . Because minor microbial populations have the potential to bloom, the temporal variation observed in a host may be mirrored by the inter-individual variation observed at a single time point 27 ; that the system is dynamic suggests that there are greater interpersonal similarities than a snap-shot view indicates. However, large perturbations such as antibiotic exposure 37 studied the distal gut microbiome in lean and obese human twins and their mothers. Significant or substantial taxonomic variation was observed among the individuals, although Firmicutes and Bacteroidetes still constituted most of the taxa that were found in the distal gut. b | Through metagenomic analyses, the functional characteristics of the microbiome, as identified by Clusters of Orthologous Groups (COG) pathway analysis, are largely conserved, despite the taxonomic variation Among all mammals, the microbiota composition is extensively conserved at high taxonomic levels 7 , but variation increases at progressively lower taxonomic levels 30 . Consequently, 85% of the sequences obtained from the distal gut of the mouse represent genera that are not detected in humans 31 . Furthermore, intraspecies variability of the microbiota among human populations is substantial 5 . This degree of variation was unanticipated a priori. In retrospect, however, extensive taxonomic variation is unsurprising: a human harbours a climax population of ~10 14 35 among human ethnic groups; however, the extent of ethnic variation in overall metagenomic composition is unknown. The microbiomes of monozygotic twins are more closely related to one another than to those of unrelated individuals 36,37 but not strikingly so, indicating important postnatal influences on composition.
Functional variation. The extensive lower-level taxonomic variation and large compositional differences observed even between highly related host organisms (for example, mice and humans) is counterbalanced by the substantial conservation of metagenomic core functions (FIG. 2) . This reflects the conservation of core bacterial properties involved in nucleic acid and protein synthesis, and in metabolic and structural requirements. Of the >50 known phyla, most of the human microbiota is composed of <10 (and mostly 6) phyla. Bacteria from other phyla, usually of plant origin, may be present in skin, nasopharyngeal or gut samples 24,25,38 ; however, these are generally infrequent (representing <0.01% of the sequences) and probably represent transient carriage from food-and air-borne exposures.
Why did the particular restriction of diversity to only a few phyla evolve not only in humans, but also in perhaps all other vertebrates? One possibility is that within the conserved boundaries for the microbiome that are permitted by the human genome, there exists a large range of contingency organisms and contingency genes. According to this hypothesis, the genes may only be active at some moment in the lifespan of the host, or perhaps at a frequency of less than once per lifespan.
The parallel needs of individual bacteria lead to both competition for key substrates and to functional redundancy in the microbiota. Nevertheless, the enormous bacterial biomass also provides many unique or minimally redundant bacterial genes 19 .
Resilience and community disturbance. Resilience, the ability to withstand disturbance, is a central concept in ecology. The resilience of the human colonic microbiome is beautifully illustrated by recent studies of twins that were examined before, during and after 7 weeks of ingesting a fermented milk product containing a sample of ~10 8 Bifidobacterium, Lactobacillus, Lactococcus and Streptococccus species 36 . Despite the daily oral inoculations, the composition of the microbiota at the 16S rDNA level and the metagenome were essentially unaffected. Although the microbiome of human adults seems to be highly resilient, no comparable studies have been carried out in children; microbial population structures seem to be more dynamic in children 39 , and so resilience may be lower. An important natural experiment has been occurring over the past 70 years in which most of the world's population have been exposed to pharmacological doses of antimicrobial
Extinction
The loss of an organism or group of organisms (usually of a species) from an ecosystem.
Enterotype
A recently proposed classification unit of animals that is based on the bacteriological composition of their gut microbiome. There are reported to be at least three distinct enterotypes, which are independent of ethnic background and diet.
Nash equilibria
Concepts from game theory in which players know the strategies of the others, and in which any change from their strategy puts them in a less favourable position.
Resilience
A term in ecology indicating the capacity of a system to absorb disturbance and to reorganize itself while undergoing change, so as to retain essentially the same function, structure and identity.
Extirpations
The loss of species in a locality (for example, an individual host).
Allelopathy
A phenomenon in which a microbe uses chemical means to aid its competition within a group of microbes. Allelopathy may involve manipulation of third parties (for example, the host) to favour competition.
Mating preference
The selection or choice of sexual partners that is often based on traits of a potential mate. Genetic differences between selected and non-selected hosts are a source of selectable variation.
agents. Such usage has been based on the implicit belief that the human microbiome is completely resilient and returns to the pretreated composition after antibioticinduced perturbation. However, studies of indicator organisms, such as H. pylori, show that individual hosts can experience extirpations of bacterial species 40 . Medium-and long-term selection of resistant organisms and the destabilization of the microbiome with new species compositions are also seen, even in the absence of further antibiotic exposure 28, 41 . Thus, despite the extensive resilience that is inherent in a complex ecosystem, there may be loss of recovery from continued perturbations 29 , which has important implications for human health 42 . Medical scientists are familiar with Koch's postulates, which are used as criteria to determine whether a microbe causes disease 43 . However, when considering the pathogenicity of the microbiome it might be better to focus on community characteristics, which are largely governed by richness, composition and interactions among the constituent members 7, 16, 44 . Substantial perturbation (community disturbance 45 ) tests the resilience of the community, such as its ability to resist invasion by exogenous microbes; stable diverse communities resist pathogens 46 . At present, 16S rRNA analyses focus on taxonomic differences at or above the species level. However, examinations below the subspecies level, relating to strains or even alleles, may be more informative. However, the technology (particularly the informatics tools) are not yet sufficiently developed for these applications.
Extinctions. The human microbiome represents one or more complete ecosystems. The trophic organization of species-rich communities is similar to other complex network topologies, in that it shows extreme heterogeneity and is dominated by a few highly connected nodes 47 . Such communities may resist random perturbations but if keystone species 48 are lost, effects may cascade, causing secondary extinctions; high biodiversity diminishes this risk 12 . The substantial nonlinear interactions present in complex, co-evolved systems ensure that ecological networks are robust against random removals 49 . However, if a system is repeatedly perturbed, the effects of gene loss can be amplified by downstream effects on co-colonizing microbes and on the host. Because of allelopathy, the effects of extinctions may be magnified 50 . In the short-term, functional redundancy may mask extinction effects but in the longer-term, extinctions lead to losses of contingency responses and cause ecological crashes 49 . Considering the importance of guilds of bacteria that exploit parallel and sequential metabolic pathways, these concepts are relevant to the human metagenome. As a result of modern lifestyles, horizontal microbial transmission has been diminishing, and there has been unprecedented selection against existing, long-present microbes 40 . An example is provided by the loss of a dominant species, H. pylori, from the human stomach 51, 52 , which has led to this body site harbouring alternative, stable states characterized by the presence or absence of H. pylori.
In summary, as with other complex ecosystems, the microbiomes that populate specific human anatomical niches are species-rich, but possess particular overall community characteristics at higher organizational levels. All are subject to perturbation in the course of normal development and ageing, and especially with disease. As our knowledge of the fundamental characteristics and biology of the human microbiome grows, so will our ability to understand disease-related variation.
Influences on the microbiota during host life cycles As described in the previous section, differences in microbiota composition exist across body sites and among individuals. However, changes are also evident across the human lifespan. Important questions in this field involve determining whether such temporal changes are life-stage-specific, and whether they are predetermined by host genetic characteristics or by environmental factors.
Inheritance of microbiota. The congruent phylogenies of mammals and their microbiota 8 provide strong evidence for the inheritance of the microbiota 7 . Although inheritance of the microbiota from the father is presently little studied, increasing evidence supports inheritance from the mother 34, 53 . Until the amniotic sac ruptures, a fetus is considered to be sterile, or essentially sterile. Immediately after vaginal delivery, founding microbial populations in the baby closely resemble that of their mother's vagina 54 , with lactobacilli predominating. Because lactic-acid-producing bacteria dominate in both the mother's vagina and milk, the initial bloom of lactobacilli in the baby's gastrointestinal tract cannot be considered accidental. Lactobacilli represent the pioneer community in mice 55 and humans
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, in which they prepare the gastrointestinal tract for subsequent microbial successions until microbial maturity is reached.
The repeated opportunities for the microbiota to be transferred from a mother to her baby may be disrupted by modern lifestyles. The availability of delivery by Caesarean section, as opposed to vaginal delivery, is an obvious example of the potential impact of medical practice on microbiota composition; substantial differences in the founding microbiota population 54 can persist for months 56 (FIG. 3) . In many host species, paternal contributions to offspring traits have been well documented 57,58 ; these observations have been extended to the microbiome, in which paternal contributions to H. pylori allele composition in the offspring have been shown 59 . In any event, there is evidence for extensive horizontal transfer of microbial genes within human populations, involving microbes in different functional classes and inhabiting different ecological niches 60 , indicating the site-specificity and dynamism of selection on the human microbiome. Even so, microbial inheritance can provide important confirmation of human ancestry 61 Acquisition is modified by differences in offspring genetics and epigenetics (with respect to both maternal and paternal genes) that inform the competition for host resources by the vertically transmitted or environmentally acquired microbes. Ancestral organisms that have particular tissue-specific and niche-specific adaptations facilitate tissue tropisms and are selected for, thus explaining the conserved niche-specificity compositions.
in humans? Odour is one means to affect mating preference, and human axillary and oral odours are largely influenced by microbial products, especially mercaptans 63 . In general, the greater the force of mating preference, the more likely that those populations will become sexually isolated 64, 65 ; this could affect tribal differentiation and other ethnic differences in humans. We speculate that metagenome composition has affected mating preference in humans, representing another phenotype under strong selective pressure.
Postnatal influences on the microbiota. Over a lifetime, each human develops a densely populated microbiome, a process that is recapitulated in every individual and in every generation. The eruption of teeth is responsible for major successions in the oral microbiota 66, 67 , suggesting that succession may be a general property of microbiome dynamics in humans. In mice, succession clearly occurs in the gastrointestinal tract 68 . Exposure (or not) to environmental microbes is another important, but highly variable, reservoir for the resident microbiota. Antibiotic use in early life produces major shifts in both microbiota characteristics and in host developmental phenotypes, in both farm animals 69 and experimental animals 70, 71 . Whether such precedents are applicable to human children is unknown, but it seems likely. If so, then both the timing of microbiome succession and the specific organisms that are present may affect development. The concept of time-dependent compositional variation affecting host immunological, metabolic, cognitive and reproductive development is a potentially important and testable hypothesis. We further speculate that nature orchestrates microbiome development to optimize fecundity, reaching a climax state at or near parturition to maximize success for the next generation of hosts. The noted heterozygote advantage for fecundity 72 may be an analogue of harbouring a genetically diverse microbiota.
Microbiome dynamics in adults. Our knowledge of microbiome dynamics, especially age-related changes during human adulthood, is limited. The older literature (predating the use of HTS), clearly shows that the postmenopausal vaginal microbiota differs substantially from that during the reproductive period 73, 74 . Similarly, in the stomach, the age-related progressive development of gastric atrophy (which is enhanced by the presence of H. pylori 75, 76 ) selects for gastric microbiota that are substantially different from those that are found in the stomach of younger, H. pylori-negative hosts 77 . Analogous changes may be occurring in other body sites as senescence advances. In the gut, the ratio of Bacteroidete to Firmicute species changes with age 78 . These concepts are particularly relevant to oncogenesis, which is generally age-related. In the multistep Nordling hypothesis of oncogenesis 79 , 4-6 somatic cell mutations are needed for cancer development. We propose that shifts in age-related microbiota contribute to this multistep process. Residential microbes can contribute to somatic mutagenesis by causing genotoxicity as a result of inflammation, increased cell proliferation and the production of pro-mutagenic metabolites (for example, butyrate) 80 . Genes may have alternative effects at different life stages, illustrating the idea of antagonistic pleiotropy 81 . We hypothesize that specific human microbiota and their genes that are beneficial early in life may be harmful later in life. The dominant gastric bacterium H. pylori provides an example: early in life, inflammatory responses in the host improve the control of infection 82, 83 and allergy 84 , but later in life promote atrophy and oncogenesis 85 . A related hypothesis is that co-evolved microbiota are adaptive for the human species both by supporting early-in-life host functions and by leading to later-in-life host demise 86 .
Disease links and health implications
Overall, how does the microbiome affect human health? Current studies focus on describing the variant microbe populations that occur in specific disease states, or the temporal microbial changes that are observed over the course of a disease. For many conditions, the challenge is to discover whether there is a causal link between microbiome variation and pathology. Unfortunately, limitations in the definitions and stratification of clinical syndromes, including irritable bowel syndrome and non-ulcer dyspepsia (NUD), reduce the potential of microbiome studies. Below, we review some recent investigations into specific diseases (TABLE 1) ; these investigations are preliminary but some observations are promising. Cardiovascular disease Gut-microbiota-dependent metabolism of phosphatidylcholine 136
Antecubital fossae
The triangular areas on the anterior (flexor) aspects of elbow joints.
Popliteal fossae
The shallow depressions that are found on the flexor aspects of knee joints.
Pilosebaceous units
The anatomic structure around each hair shaft that consists of the hair shaft and follicle, the sebaceous gland and the erector pili muscle.
Amphibiont
An organism (for example, a microbe) that may have a pathogenic or symbiotic relationship with another organism (for example, its host), depending on context. This is a more specific term than commensal.
The cutaneous microbiome. The cutaneous microbiome is an obvious target in specific diseases such as psoriasis, a chronic, idiopathic inflammatory dermatological condition 87 . In studies predating HTS, the use of PCR and cloning led to observations that Firmicute species were significantly over-represented and that Actinobacteria were significantly under-represented in psoriatic lesions compared with both unaffected skin in patients with psoriasis and in unaffected controls 88 . Studies to explore these findings using HTS are currently underway 89 . Atopic dermatitis, another chronic inflammatory condition, has increased in incidence approximately threefold over the last 30 years in industrialized countries, suggesting a potential role for microbiome alterations. Classic atopic dermatitis occurs in skin regions, such as the antecubital fossae and the popliteal fossae, that have similar microbial populations 89 , suggesting a microbiome role. Similarly, Propionibacterium acnes has been implicated in the common dermatological condition, acne. P. acnes thrives in the cutaneous pilosebaceous units, secretes enzymes that cause local injury and inflammation, and is widely accepted to have a function in acne development 90 . However, investigations are ongoing to examine the involvement of other microbes in the development of acne. Chronic skin ulcers, which are often secondary to venous stasis or diabetes, lead to substantial morbidity. Cutaneous microbiome shifts have been noted in these conditions, such as an increased abundance of Pseudomonadaceae in patients with chronic ulcers that were treated with antibiotics, and an increased abundance of Streptococcaceae in diabetic ulcers 91 . Such shifts may interact with aberrantly expressed host cutaneous defence response genes 92 , thereby increasing disease risk.
The gastric microbiome. The discovery that H. pylori was adapted to survive in the acidic gastric environment overturned the dogma that the stomach is sterile. In H. pylori-negative individuals, gastric microbiota diversity is high; most of the prominent gastric phylotypes (Streptococcus, Actinomyces, Prevotella and Gemella) also are abundant in the oropharynx of these individuals 93 ; this indicates either that many constituents are swallowed from more proximal sites, or that close relatives of the oral microbiota colonize more distally. By contrast, among H. pylori-positive individuals, H. pylori usually accounts for >90% of sequence reads from the gastric microbiota 93 , markedly reducing the overall diversity of this microbiota. The ability of H. pylori to dominate the gastric microbiota indicates an evolved fitness for that specialized niche. H. pylori is a classical amphibiont; the presence (or absence) of an H. pylori-dominated gastric microbiota is strongly associated with particular diseases that show important age-related differences 85 . Its presence increases risks for developing peptic ulcer disease, gastric mucosa-associated lymphoid tissue (MALT) tumours, and gastric adenocarcinomas 94 . Conversely, it is also associated with a decreased risk of reflux oesophagitis 95 and childhood-onset asthma 96 , thus demonstrating the complex biological interactions between hosts and microbiota.
The colonic microbiota and colorectal cancer. The colonic microbiota has been suspected for a long time to be involved in the development of colorectal cancers 97 , possibly by synthesizing short-chain fatty acids (SCFAs) and other metabolites. SCFAs, in particular butyrate, may induce apoptosis, cell cycle arrest and differentiation, through WNT signalling 98 . Microbes may also be genotoxic to colonic epithelial cells, as demonstrated by the induction of aneuploidy and tetraploidy by Enterococcus faecalis 99 . The colonic microbiota might also promote colorectal cancer by eliciting host responses, for example, by stimulating exaggerated immune responses, potentially through T helper 17 (Th17) cells 99 . Further evidence of a link between colonic microbiota and colorectal cancer is suggested by the ability of antibiotic administration to not only alter the composition of the colonic microbiota but also to affect the expression of host genes that are involved in cell cycle regulation, thus reducing epithelial proliferation 100 . Early studies evaluating specific microbes were limited to identifying culture-dependent species, such as Streptococcus bovis, but could not adequately assess anaerobic constituents. However, members of the anaerobic genus Fusobacterium have recently been associated with colorectal cancer: whole-genome sequences of Fusobacterium species were compared between tumour tissue and matched normal colon tissue using both quantitative PCR analysis and HTS 101, 102 . Fusobacterium nucleatum is a mucosally adherent, pro-inflammatory microbe that was first
Lamina propria
A thin layer of loose connective tissue that lies underneath the epithelium; collectively these tissues constitute the mucosa that line various lumens in the body. The lamina propria is densely populated by immunological and inflammatory cells.
Steatosis
The pathological accumulation and retention of lipids in liver parenchymal cells. Substantial steatosis can compromise cellular functions and is associated with disease processes, including alcoholism, diabetes and hyperlipidaemia.
Commensals
Organisms (for example, microbes) that are involved in a form of symbiosis in which one organism derives a benefit while the other is unaffected.
Probiotic
Living microorganisms that are thought to confer a benefit to the host.
Roux-en-Y surgery
A type of gastric bypass surgery that is primarily used for the treatment of morbid obesity. In Roux-en-Y surgeries, a portion of the small bowel is bypassed to decrease the absorption of nutrients.
Dysbiosis
A condition in which the normal microbiome population structure is disturbed, often through external pressures such as disease states or medications.
identified in the mouth 103 . In colorectal cancer samples, F. nucleatum sequences were significantly enriched compared with samples obtained from control tissue, while both Bacteroidetes and Firmicutes were depleted relative to other bacteria in Fusobacterium-rich malignancies 102 . The enrichment of Fusobacterium species (not limited to F. nucleatum) was confirmed when evaluating the mucosal microbiome of colorectal cancers compared to adjacent normal tissues in an expanded collection of 99 biopsies 101 . However, the causal direction of the association has not yet been ascertained.
The colon microbiota and inflammatory bowel disease.
The microbiome is essential for the activation of host immune responses 104 . For example, Th17 cell differentiation in the mouse lamina propria requires the presence of segmented filamentous bacteria (SFB) 105 , and polysaccharide A produced by Bacteroides fragilis mediates the conversion of CD4 + T cells into regulatory T cells 106 . The inflammatory bowel diseases have long been considered to reflect interactions between microbes and the host. IBD susceptibility is associated with host polymorphisms in bacterial sensor genes such as nucleotide-binding oligomerization domain-containing 2 (NOD2; also known as caspase recruitment domain-containing protein 15 (CARD15)) 107, 108 and Toll-like receptor 4 (TLR4) 109 , and symptoms in patients with IBD sometimes improve following antibiotic treatment 110 . Early childhood exposure to antibiotics has been associated with a significantly increased risk for Crohn's disease 111 , suggesting that gut microbiome perturbations are important for disease risk. Microbial diversity is significantly diminished in Crohn's disease 112 , suggesting a decreased gut microbiome resilience that could affect immune interactions. Gut microbiome population structures in patients with ulcerative colitis or Crohn's disease 19 depart from normality, but remain clustered by disease within their characteristic deviated patterns. Specific bacteria of the Enterobacteriaceae family may act together with a disordered microbiome to increase the risk of ulcerative colitis 113 . Between twins that are discordant for ulcerative colitis, those affected had significantly reduced bacterial diversity, but increased proportions of Actinobacteria and Proteobacteria 114 . Patients with Crohn's disease have over-representation of Enterococcus faecium and of several Proteobacteria compared with controls 115 . The microbial patterns observed for the conditions described above are preliminary, and their specificity and causal direction have not been established.
The gut microbiota and diseases of the liver. The gut microbiota may be involved in hepatological conditions, including non-alcoholic fatty liver disease (NAFLD) 116 , alcoholic steatosis and hepatocellular carcinoma. The liver is the first solid organ to be exposed to the metabolic products that are generated by the gut microbiome, including acetaldehyde, ammonia and phenols. Compared with germ-free mice, the presence of a microbiome in normal mice leads to the suppression of intestinal epithelium angiopoietinrelated protein 4, which normally inhibits lipoprotein lipase; this microbiome-mediated effect consequently increases downstream triglyceride accumulation in the hepatic parenchyma and adipocytes 117 . Chronic exposure to ethanol disturbs the gut microbiome 118, 119 , but roles for the microbiome in steatosis are unresolved. Particular colonic commensals of the mouse (for example, Helicobacter hepaticus) promote the development of hepatocellular carcinoma 120 . Patients with cirrhosis have a substantially altered microbiome, including communitywide changes at multiple taxonomic levels, with enrichment of Proteobacteria and Fusobacteria phyla, and of Enterobacteriaceae, Veillonellaceae and Streptococcaceae families 121 . Although many observations suggest links between microbiome composition and liver disease, definitive associations in humans are lacking.
The gut microbiota and obesity. Genetically obese (ob/ob) mice have decreased Bacteroidetes/Firmicutes ratios compared with their lean (ob/+ and +/+ wildtype) siblings 31 . Transplantation of gut microbiota from the obese (ob/ob) to germ-free mice conferred an obese phenotype, demonstrating the transmissibility of metabolic phenotypes 17 ; the transferred microbiomes had increased capacities for energy harvest. In humans, the relative proportions of members of the Bacteroidete phylum increase with weight loss 122 . In studies of monozygotic and dizygotic twins, obesity was associated with smaller populations of Bacteroidetes, diminished bacterial diversity and enrichment of genes related to lipid and carbohydrate metabolism. Despite substantial taxonomic variation, functional metagenomic differences were minor 37 . Modern lifestyles that change the selection pressures on microbiomes could alter exposures to bacteria during the early lives of hosts and thus may contribute to the development of obesity. Antibiotic use in human infancy (before the age of 6 months) was significantly associated with obesity development 123 . By contrast, perinatal administration of a Lactobacillus rhamnosus probiotic decreased excessive weight gain during childhood 124 . These early studies provide support for the concept that perturbations in microbiota could lead to childhood-onset obesity, which might be modifiable. Alterations in the gut microbiome also occur when interventions are used to treat obesity. Roux-en-Y surgery significantly increases levels of Proteobacteria and alters specific metabolic markers, such as the production of urinary amines and cresols 125 .
The gut microbiota and rheumatoid arthritis. Dysregulation of host responses as a consequence of dysbiosis in the gut lumen could affect distant anatomical sites through the activation of host immune responses. This could be the mechanism that contributes to rheumatoid arthritis, which is another chronic idiopathic inflammatory condition. In mice, the presence of SFBs in the gut microbiome causes the local expansion of Th17 cells 126 , which then migrate to peripheral immune compartments and activate B cells into antibodyproducing plasma cells. Antibody production leads to the immune-mediated destruction of joints, which occurs in rheumatoid arthritis 127 . • Well-controlled microbial variability
• Physiologically less well-understood than normal animals • 'Artificial' colonization using known microbiota may not be representative of the real-world situation
Gnotobiotic
Describes an animal that is colonized solely by known strains of bacteria or other microorganisms. The term also describes germ-free animals, as the status of their microbial communities is known.
Conventionalization
A method in which germ-free animals (particularly mice) are inoculated with gut microbiota to populate the gastrointestinal tract.
Cause or effect?
Microbiome analysis in humans has been largely based on observation; that is, associations of disease phenotypes with particular microbiota constituents. But which is causal: does factor A cause factor B, does factor B cause factor A or does factor C cause both A and B? Hill 128 developed criteria to address the questions: "In what circumstances can we pass from this observed association to a verdict of causation? Upon what basis should we proceed to do so?" The criteria include: the strength of association, including its consistency, specificity, temporality and biological plausibility; whether biological gradients are present; whether experimental support exists; and whether support can be extrapolated from known causal relationships. Although these criteria were advanced largely to unravel epidemiological relationships, they are applicable to genetics and particularly to metagenomics. Sometimes successful treatment trials that achieve the amelioration or cure of a particular condition provide the crucial evidence for a causal relationship. The changed natural history of peptic ulcer disease following the elimination of H. pylori 129 demonstrated the pathogenic role of this bacterium.
Model organisms provide an important approach for understanding causation and pathogenesis. Animal models approximate some human diseases (for example, asthma and atherosclerosis), but cannot yet accurately reproduce many diseases (for example, psoriasis). For diseases that can be studied in model organisms, the roles of microbiota can be explored within the constraints of particular model systems (TABLE 2) . Standard models of inbred mice are limited by their uncontrolled microbiome diversity. Certain disease states are wellstudied in these models, such as the effects of SFBs on Th17 development or the susceptibility to type 1 diabetes in non-obese diabetic (NOD) mice. The use of gnotobiotic mice eliminates the above-mentioned microbiome variability, but the animals are expensive and require specialized facilities and expertise, which limits their widespread use. The recent availability of gnotobiotic animals from commercial sources permits the conventionalization of animals harbouring experimental or control microbiota without needing xenobiotic facilities; such approaches allow for the direct observation of the effects of microbiota on the host. The extension of this concept to humanized model organisms 130 allows better approximation of the effects of the human microbiome on disease processes in tractable animal models.
Perspectives
Inherent complexities in the composition of the microbiome may preclude investigations of microbe-associated diseases using classical approaches such as Koch's postulates. Instead of single organisms being associated with disease, community characteristics (such as composition and metagenomic functionality) may be more relevant. The principles of host interactions with pathogens and commensals share many features, and this may inform the new field; however, the nature of the selection for commensalism is more complex and dynamic than pathogen-host interactions. The scale of the interface suggests that microbiome-host interactions have important bearings on disease susceptibility, and the microbial effects on the balance of host metabolism and immunity 131 provide an excellent model for the broader phenomenon of disease susceptibility. Altering metabolic, immunological or developmental pathways are obvious strategies for modifying disease risk.
Given the ongoing extinction of our ancient commensal organisms, the future of a healthy human microbiome may include the restoration of our ancestral microbial ecology. There are two types of restoration. The first involves restoring ancient organisms (or pathways) in healthy hosts that lack them, as prophylaxis against future imbalances. The second type of Prebiotics Food ingredients that confer specific changes in the gut microbiome and lead to beneficial effects in the host.
Operational taxonomic unit
(OTU). The smallest phylogenetic unit described by variations in 16S ribosomal RNA sequencing. Dissimilarity of <1% in 16S rRNA sequences has commonly been used to define an OTU but <3% and <5% have also been used.
Non-coexistence
An exclusivity scenario in which the abundance of one species leads to another species being less abundant than would be expected by chance.
restoration could be therapeutic, when the aetiological extinctions and imbalances are recognized. This scientific frontier will require an understanding of the biology of re-introductions, as well as developing microbial breeding programmes. In addition to the technical problems that are associated with restoring particular organisms in specific hard-to-reach niches (such as the distal ileum), there also will be substantial biological problems related to understanding how re-introductions affect the population structure of the extant organisms and their interactions with the host.
To better understand the implications of microbiota and metagenome variation in human health and disease, the field needs improved informatics tools, including new approaches for understanding the complexity of the metadata 60 . The multidimensionality of the human and microbial phenotypes (and the dynamic, nonlinear interactions) creates challenges for identifying deterministic solutions. For example, in analyses of 16S-rRNA-defined operational taxonomic unit (OTU) populations in mice that received either traditional or Western-type diets, Reshef et al. 132 examined top-scoring nonlinear abundance relationships. These often involved 'non-coexistence' that was sometimes related to known factors (for example, diet or host gender) but was often unexplained. Although incomplete, such work leads to new approaches for understanding the underlying complexity.
We also will need new tools to implement the findings of metagenomic analyses that are relevant to human health. Although the known principles of evolution and genetics apply, studies of microbiomes provide new applications, and will lead to new understandings of complex traits. Important questions to pursue are listed in BOX 1. As such, this is a frontier for human preventive medicine and for the medical management of chronic diseases. 
